A Study of Single and Multiple Dose Administration of LP-001 in Healthy Subjects

Conditions: Myelodysplastic Syndrome (MDS) Interventions: Biological: LP-001 Dose 1 (Single); Biological: LP-001 Dose 2 (Single); Biological: LP-001 Dose 3 (Single); Biological: LP-001 Dose 4 (Single); Biological: LP-001 Dose 5 (Single); Biological: LP-001 Dose 6 (Single); Biological: Placebo (Single); Biological: LP-001 Dose 7 (Multiple); Biological: LP-001 Dose 8 (Multiple); Biological: Placebo (Multiple) Sponsors: Longbio Pharma Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials